Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 USD | -12.62% | -37.72% | -69.01% |
02/05 | Nuwellis, Inc. Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology | CI |
29/04 | Maxim Downgrades Nuwellis to Hold | MT |
Sales 2024 * | 10.16M 847M | Sales 2025 * | 11.78M 982M | Capitalization | 3.14M 261M |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.58B | Net income 2025 * | -16M -1.33B | EV / Sales 2024 * | 0.31 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.27 x |
P/E ratio 2024 * |
-0.12
x | P/E ratio 2025 * |
-0.42
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.97% |
Latest transcript on Nuwellis, Inc.
1 day | -12.62% | ||
1 week | -37.72% | ||
Current month | +16.58% | ||
1 month | -52.76% | ||
3 months | -62.50% | ||
6 months | -74.63% | ||
Current year | -69.01% |
Managers | Title | Age | Since |
---|---|---|---|
Nestor Jaramillo
CEO | Chief Executive Officer | 66 | 07/19/07 |
Robert Scott
DFI | Director of Finance/CFO | 44 | 01/13/01 |
John Erb
CHM | Chairman | 75 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Erb
CHM | Chairman | 75 | 01/12/01 |
Director/Board Member | 61 | 01/11 | |
Gregory Waller
BRD | Director/Board Member | 74 | 03/11/03 |
Date | Price | Change | Volume |
---|---|---|---|
04/24/04 | 0.18 | -12.62% | 10 781 085 |
02/24/02 | 0.206 | +54.89% | 72,293,040 |
01/24/01 | 0.133 | -13.86% | 2,893,529 |
30/24/30 | 0.1544 | +7.22% | 2,220,577 |
29/24/29 | 0.144 | -14.18% | 4,853,954 |
Delayed Quote Nasdaq, May 04, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.01% | 3.14M | |
+7.84% | 218B | |
+7.35% | 183B | |
+13.04% | 134B | |
+26.03% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
+0.30% | 40.3B | |
+2.78% | 35.53B | |
+26.14% | 32.05B |
- Stock Market
- Equities
- NUWE Stock